Publication | Open Access
The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation
48
Citations
38
References
2000
Year
Signal TransductionSignaling PathwayReceptor Tyrosine KinaseT-regulatory CellImmunologyCell DeathImmunologic MechanismHsp90-specific Inhibitor GeldanamycinT-lymphocyte ActivationImmunotherapyMedicineCell BiologyCell Signaling
| Year | Citations | |
|---|---|---|
Page 1
Page 1